Cargando…
Characterizing the Developmental Trajectory of Sirolimus Clearance in Neonates and Infants
Sirolimus is increasingly being used in neonates and infants, but the mechanistic basis of age‐dependent changes in sirolimus disposition has not been fully addressed yet. In order to characterize the age‐dependent changes, serial sirolimus clearance (CL) estimates in individual young pediatric pati...
Autores principales: | Emoto, C, Fukuda, T, Mizuno, T, Schniedewind, B, Christians, Uwe, Adams, DM, Vinks, AA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999604/ https://www.ncbi.nlm.nih.gov/pubmed/27501453 http://dx.doi.org/10.1002/psp4.12096 |
Ejemplares similares
-
Development of a Pediatric Physiologically Based Pharmacokinetic Model for Sirolimus: Applying Principles of Growth and Maturation in Neonates and Infants
por: Emoto, C, et al.
Publicado: (2015) -
Development of a Physiologically-Based Pharmacokinetic Model for Sirolimus: Predicting Bioavailability Based on Intestinal CYP3A Content
por: Emoto, C, et al.
Publicado: (2013) -
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
por: Emoto, Chie, et al.
Publicado: (2018) -
Characterization of Contributing Factors to Variability in Morphine Clearance Through PBPK Modeling Implemented With OCT1 Transporter
por: Emoto, C, et al.
Publicado: (2016) -
Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
por: Bohra, Rahul, et al.
Publicado: (2012)